I have been a professional equity research analyst and investor in biopharma stocks for the past two decades. I am a former bench scientist turned financial analysts. My company, BioNap, Inc., is an investor awareness and biopharma market research firm dedicated to helping both biopharma companies and investors make better decisions when it comes to investment in the healthcare industry.
I have significant experience in financial modeling and product competitive analysis. I previously worked for Zacks Investment Research covering the small and mid-cap biotechnology and specialty pharmaceutical industry between 2003 and 2015. Before Zacks, I spent three years on the buy-side with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology.
Before joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases. I also spent a year working in a lab at the Fralin Biotechnology Center in Blacksburg, VA. I have a B.S. in Biochemistry from Virginia Tech and an M.B.A. with a concentration in Securities Analysis from Wake Forest University. I am a Chartered Financial Analyst (CFA).